A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic Purpura

NCT00002250 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Immune Thrombocytopenic Purpura ( ITP )
HIV Infections

Interventions

DRUG: CD4-IgG

Sponsor

Genentech, Inc.